Real-world study on first-line immunochemotherapy in advanced gastric/gastroesophageal junction cancer (GC/GEJC): Predicting response with peripheral immune landscape.
Year: 2025
Type: article
Source: Journal of Clinical Oncology
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4410809951
